10-Q: Q2 2024 Earnings Report
Cyclo Therapeutics Announces Notice of Decision to Grant European Patent Application for Treatment of Alzheimer's Disease From European Patent Office
10-Q: Q1 2024 Earnings Report
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol Cyclo for the Treatment of Alzheimer's Disease
Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer's Disease From the U.S. Patent and Trademark Office